Can Belgian doctor Hans Kluge win the race to lead the WHO?

Belgium’s federal government nominated Belgian doctor Hans Kluge

Organisation

World Health Organization

United Nations health agency choosing its next Director-General through a member-state process.

Why it matters

United Nations health agency choosing its next Director-General through a member-state process.

About

The World Health Organization (WHO) is a specialized agency of the United Nations (UN) which coordinates responses to international public health issues and emergencies. It is headquartered in Geneva, Switzerland, and has six regional offices and 150 field offices worldwide. Only sovereign states are eligible to join, and it is the largest intergovernmental health organization at the international level.

Official site ↗View source record ↗

Kluge confirmed the move publicly, saying Belgium had nominated him and that he was honoured by the confidence placed in him. Euractiv reported that he took special leave from his regional role on 21 August, as required by WHO election procedures. Corinne Capuano, WHO Europe’s Director of Programme Management, is handling the regional office’s work during his absence. That safeguard matters because Kluge is not merely campaigning from outside the organisation: he has been responsible for its work across a 53-country European region stretching into Central Asia.

The candidacy turns a Belgian public-health career into a bid for one of the most politically exposed jobs in international health. Born in Roeselare, Kluge qualified in medicine, surgery and obstetrics at KU Leuven in 1994 and completed tropical-medicine training at Antwerp’s Institute of Tropical Medicine in 1995, according to his official WHO biography. He began as a family doctor before joining Médecins Sans Frontières Belgium, working on health emergencies and tuberculosis programmes in Liberia, Somalia and prisons in Siberia.

Kluge joined the WHO in 1999 and subsequently worked on tuberculosis, HIV and health systems in Russia, Myanmar and other countries. He moved to the organisation’s European office in 2009 and became Regional Director in February 2020, just as Covid-19 developed into a global emergency. The WHO Executive Board appointed him to a second five-year regional term in February 2025 after the European region’s member states unanimously renominated him. That record gives Belgium’s candidate an evident argument: he combines field medicine, institutional experience and recent crisis management.

It does not give him a clear path to victory. The WHO’s prospective-candidate register also lists Hanan Mohammed Al-Kuwari, proposed by Qatar; Hanan Balkhy, proposed by Saudi Arabia; and Indonesian Health Minister Budi Gunadi Sadikin, proposed by Indonesia. More nominations can arrive before the September deadline. The Executive Board will assess the field at its 160th session in 2027 and nominate no more than three candidates. The World Health Assembly

Organisation

World Health Assembly

WHO decision-making forum due to appoint the next Director-General in May 2027.

Why it matters

WHO decision-making forum due to appoint the next Director-General in May 2027.

About

The World Health Assembly (WHA) is the forum through which the World Health Organization (WHO) is governed by its 193 member states. It is the world's highest health policy setting body and is composed of health ministers from member states.

Official site ↗View source record ↗

This is therefore a diplomatic campaign as much as a professional selection. Belgium can propose Kluge, but it cannot elect him. Winning will require support across regional blocs and among governments with sharply different expectations of the WHO. The federal level is responsible for presenting and promoting Belgium’s candidate internationally: Vandenbroucke holds the relevant public-health portfolio, while Vice-Prime Minister and Minister of Foreign Affairs, European Affairs and Development Cooperation Maxime Prévot oversees the diplomatic network that can canvass member states. Belgium’s regions and communities possess extensive domestic health responsibilities, including important prevention and care functions, but they do not individually nominate candidates for this intergovernmental post.

For Prime Minister Bart De Wever’s federal coalition, formed after the June 2024 election and currently governing in the 2024–2029 legislative cycle, Kluge’s candidacy is an exercise in multilateral influence rather than a change to Belgian healthcare policy. A victory would give a Belgian national unusual visibility at the centre of pandemic preparedness, disease surveillance, vaccination standards and health-emergency coordination. It would not place the WHO under Belgian control: the Director-General is accountable to the organisation’s governing bodies and its full membership, not to the nominating state.

Two competing ideas of the next Director-General’s mandate are already visible. The Belgian government’s choice presents long institutional experience and continuity as assets at a moment of instability. Kluge has argued that the WHO must adapt to geopolitical realities while remaining focused on core public-health work, Euractiv reported. His unanimous European renomination in 2024 also allows supporters to point to an established capacity to work across politically divided states.

A contrasting frame comes from governments questioning the WHO’s performance and independence. The United States, in explaining its withdrawal, accused the organisation of failures during Covid-19 and of compromising its independence; the WHO rejected that account and said withdrawal made both the United States and the world less safe. This constituency will expect the next leader to demonstrate tighter priorities, greater accountability and political neutrality rather than simply preserve existing structures. Separately, the Qatari, Saudi and Indonesian nominations ensure the election cannot be reduced to a European succession plan: states outside Europe may favour leadership reflecting their regions’ experience and influence in global health.

The winner will inherit an organisation under acute financial pressure. WHO member states approved a reduced base programme budget of $4.2 billion for 2026–2027, down from an earlier $5.3 billion proposal, while the organisation attributed a major funding gap to the US withdrawal and cuts by other donors. Tedros told member states in November 2025 that realignment would lead to 1,282 separations following the abolition of positions, alongside retirements and other departures. The leadership debate is consequently about choices as concrete as staffing, emergency capacity and which programmes can be protected.

Kluge’s candidacy is credible because he already operates near the summit of the WHO, but its electoral strength cannot yet be measured. The full official field will not be known until nominations close and the WHO publishes the submitted candidacies after the final regional committee meeting in early November. Belgium must now persuade governments that a European insider can both defend multilateral health cooperation and reform an organisation confronting distrust, shrinking resources and recurrent emergencies. The next revealing moments will be the final candidate list, the public candidate forums and the Executive Board shortlist in 2027.